PDE3A as a Therapeutic Target for the Modulation of Compartmentalised Cyclic Nucleotide-Dependent Signalling
Cells · 2025
DOI: 10.3390/cells14110771 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Swaroop Ranjan Pati und 2 weiteren Autor:innen. Beteiligte Einrichtung: Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany. Hauptthemen laut MEDLINE: Cyclic Nucleotide Phosphodiesterases, Type 3, Signal Transduction, Cyclic AMP. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung, Federal Ministry of Education and Research.
Abstract (Originalsprache)
Phosphodiesterase 3A (PDE3A) hydrolyses cAMP, adjusting cAMP signalling pathways with temporal and spatial accuracy. PDE3A contributes to the control of cAMP in several cellular compartments, including the plasma membrane, the cytosol, or membrane-limited organelles such as the nucleus and the sarcoplasmic reticulum. Through this ability and its expression in various cell types, it regulates a variety of cellular processes like contractility of muscle cells, gene expression, differentiation and proliferation. Dysregulated cAMP signalling causes or is associated with diseases. The therapeutic potential of PDE3A is, however, limited by the lack of specific modulators. Emerging approaches to targeting PDE3A centre on specifically addressing its catalytic domain or its cellular localisation. This review highlights the growing knowledge of PDE3A’s functions in cellular signalling and therapeutic opportunities, opening the door to more fully utilise its potential for the treatment of disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.
- Faculty of Biology, Chemistry, Pharmacy, Freie Universität Berlin, 14195 Berlin, Germany.
- DZHK (German Centre for Cardiovascular Research), Partner Site, 10785 Berlin, Germany.
ORCID-Profile: Anastasiia Sholokh, Enno Klussmann
Förderung
- Deutsche Forschungsgemeinschaft
- Else Kröner-Fresenius-Stiftung
- Federal Ministry of Education and Research
- Federal Ministry for Education and Science
Zitieren
APA
Pati, S. R., Sholokh, A., & Klussmann, E. (2025). PDE3A as a Therapeutic Target for the Modulation of Compartmentalised Cyclic Nucleotide-Dependent Signalling. Cells. https://doi.org/10.3390/cells14110771
Vancouver
Pati SR, Sholokh A, Klussmann E. PDE3A as a Therapeutic Target for the Modulation of Compartmentalised Cyclic Nucleotide-Dependent Signalling. Cells. 2025. doi:10.3390/cells14110771
BibTeX
@article{Pati2025,
author = {Pati, Swaroop Ranjan and Sholokh, Anastasiia and Klussmann, Enno},
title = {PDE3A as a Therapeutic Target for the Modulation of Compartmentalised Cyclic Nucleotide-Dependent Signalling},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14110771}
}
EUVIMED